Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 750-758

  Karlsson, Jan Olof G ^a,e   Mortensen, E ^b   Pedersen, H K ^c   Sager, G ^b   Refsum, H ^d,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e NYCOMED IMAGING AS   (Norway)

Author keywords

Acute ischaemic heart failure, MR imaging; Cardiovascular effects; Contrast media, mangafodipir trisodium; Experimental

Indexed keywords

CHLORIDE; CONTRAST MEDIUM; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; MANGANESE CHLORIDE; MANGANESE DERIVATIVE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ACUTE DISEASE; ANIMAL; ARTICLE; CARDIOVASCULAR SYSTEM; CHEMICAL PHENOMENA; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DISEASE MODEL; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY; TIME;

ACUTE DISEASE; ANIMALS; CARDIOVASCULAR SYSTEM; CHLORIDES; CONTRAST MEDIA; DEPRESSION, CHEMICAL; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EDETIC ACID; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; MALE; MANGANESE; MANGANESE COMPOUNDS; MYOCARDIAL ISCHEMIA; PYRIDOXAL PHOSPHATE; TIME FACTORS;

EID: 0031183995     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172408     Document Type: Article

References (43)

1. ALTMAN G. A.: Practical statistics for medical research. Chapman & Hall, London 1995.
2. 2-induced endothelium-dependent relaxation in bovine mesenteric arteries. J. Pharmacol. Exp. Ther. 271 (1994), 609.
3. BERNARDINO M. E., YOUNG S. W., LEE J. K. T. & WEINREB J. C.: Hepatic MR imaging with MnDPDP. Safety, image quality, and sensitivity. Radiology 183 (1992), 53.
4. BRUROK H., SCHOTT J., BERG K., KARLSSON J. O. G. & JYNGE P.: Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate-, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused heart. Invest. Radiol. 30 (1995), 159.
5. CONRAD L. L., TRENDLEY R. L. & BAXTER D. J.: Positive inotropic effect of manganese in dog myocardium. Am. J. Physiol. 210 (1966), 357.
6. Cox R. H.: Influence of pentoparbital anaesthesia on cardiovascular function in trained dogs. Am. J. Physiol. 223 (1972), 651.
7. Cox R. H. & BAGSHAW R. J.: Influence of anaesthesia on the response to cartotid hypotension in dogs. Am. J. Physiol. 237 (1979), 817.
8. DAVIDSSON L., LÖNNERDAL B., SANDSTRÖM B., KUNZ C. & KEEN K. L.: Identification of transferrin as the major plasma carrier for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 119 (1989), 1461.
9. 2+ across the cell membrane in the guinea pig myocardium. Circ. Res. 36 (1975), 713.
10. ELIZONDO G., FRETZ C. J., STARK D. D. et al.: Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary agent for MR imaging. Radiology 178 (1991), 73.
11. GRANT D., ZECH K. & HOLTZ E.: Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 29, Suppl. 2 (1994), S249.
12. HAGIWARA S. & NAKAJIMA S.: Difference in Na and Ca spikes as examined by application of tetrodotoxin, procaine, and manganese ions. J. Gen. Physiol. 49 (1966), 793.
13. HIRATA Y., KODAMA I., IWAMURA N., SHIMZU T., TOYAMA J. & YAMADA K.: Effects of verapamil on canine Purkinje fibers and ventricular muscle fibers with particular reference to the alteration of action potential duration after sudden increase in driving rate. Cardiovasc. Res. 13 (1979), 1.
14. HOTVEDT R., PLATOU E. S., KOPPANG E. R. & REFSUM H.: Pentobarbital plasma concentrations and cardiac electrophysiology during prolonged pentobarbital infusion in the dog. Acta Anaesthesiol. Scand. 26 (1982), 638.
15. 2. Acta Radiol. 38 (1997), 740.
16. JYNGE P., BRUROK H., ASPLUND A. et al.: Cardiovascular safety of MnDPDP. Experience from ex vivo and in vivo animal experiments, in: New developments in contrast agent research, pp. 83-105. Proc. 4th Spec. Topic Semin. Eur. Magn. Reson. Forum, Santiago de Compostela, Spain, 28-30 September 1994. Edited by P. A. Rinck & R. N. Muller.
17. KASS R. S. & TSIEN R.: Multiple effects of calcium antagonists on the plateau currents in cardiac Purkinje fibres. J. Gen. Physiol. 66 1975), 169.
18. KASTEN T. P., SETTLE S. L., MISKO T. P., CURRIE M. G. & NICKOLS G. A.: Manganese potentiations of nitric oxide-mediated vascular relaxation. Eur. J. Pharmacol. 253 (1994), 35.
19. KATZ A. M.: Physiology of the heart. Raven Press Ltd, New York, 1992.
20. KLIGFIELD P., CHARASH B., PLACER E. & SOS T. A.: Antiarrhythmic effect of manganese chloride in infarcted dogs with observations on the dose-related response of heart rate and ventricular pressure. J. Pharmacol. Exp. Ther. 218 (1981), 289.
21. KOHLHART M., BAUER B., KRAUSE H. & FLECKENSTEIN A.: Selective inhibition of the transmembrane Ca-conductivity of mammalian myocardial fibres by Ni, Co and Mn ions. Pflügers Arch. Gen. Physiol. 338 (1973), 115.
22. LESHIN S. J., MULLINS C. B., TEMPLETON G. H. & MITCHELL J. H.: Dimensional analysis of ventricular function. Effects of anaesthetics and thoractomy. Am. J. Physiol. 222 (1971), 540.
23. LIM K. O., STARK D. D., LEESE P. T., PFEFFERBAUM A., ROCKLAGE S. M. & QUAY S. C.: Hepatobiliary MR imaging. First human experience with Mn-DPDP. Radiology 178 (1991), 79.
24. MATSUNAGA K. & FURCHGOTT R. F.: Responses of rabbit aorta to nitric oxide and superoxide generated by ultraviolet irradiation of solutions containing inorganic nitrite. J. Pharmacol. Exp. Ther. 259 (1991), 1040.
25. MISSELWITZ B., MÜLLER A. & WEINMANN H. J.: A toxicological risk for using managanese complexes. A literature survey of existing data through several medical specialties. Invest. Radiol. 30 (1995), 611.
26. MURAD F.: Drugs used for the treatment of angina. Organic nitrates, calcium-channels blockers, and β-adrenergic antagonists. In: Goodman and Gilman's The pharmacological basis of therapeutics, pp. 763-783. Edited by A. G. Gilman et al. Pergamon Press, New York 1990.
27. ++ binding by plasma proteins. Int. J. Peptide Protein Res. 5 (1973), 279.
28. OCHI R.: The slow inward current and the the action of manganese ions in guinea-pig's myocardium. Pflügers Arch. Ges. Physiol. 316 (1970), 81.
29. OCHI R.: Manganese-dependent propagated action potentials and their depression by electrical stimulation in guinea-pig myocardium perfused by sodium-free media. J. Physiol. 263 (1976), 139.
30. OLMSTED F. & PAGE I, F.: Hemodynamic changes in dogs caused by sodium pentobarbital anaesthesia. Am. J. Physiol. 210 (1966), 817.
31. PAYET M. D., SCHAMME O. F., RUIZ-CERETTEUI E. & DENIERS J. M.: Inhibitory action of blockers of the slow inward current in the rat myocardium, a study in steady state and of rate of action. J. Mol. Cell. Cardiol. 12 (1980), 187.
32. ROCKLAGE S. M. & VANWAGONER M.: Hepatobiliary contrast agents. An overview of the delevopment of manganese dipyridoxyl diphosphate (MnDPDP). In: Liver imaging, current trends, and techniques, pp. 374-382. Edited by J. T. Ferrucci and D. D. Stark. Andover Medical Publisher Inc., Boston 1990.
33. ROUGIER R., VASSORT G., GARNIER D., GARGOUIL Y. M. & CORABOEUF E.: Existence and role of slow inward current during the frog atrial action potential. Pflügers Arch. 308 (1969), 91.
34. SAGER G., TROVIK T., SLØRDAL L. et al.: Catecholamine binding and concentrations in the acute plasma phase after surgery. Scand. J. Lab. Invest. 48 (1988), 419.
35. SMISETH O. A. & MJØS O. D.: A reproducible and stable model of acute ischemic left ventricular failure in dogs. Clin. Physiol. 2 (1982) 225.
36. SOUTHON T. E., GRANT D., BJØRNERUD A. et al.: NMR relaxation studies with MnDPDP. Acta Radiol. 38 (1997), 708.
37. 2 in the conscious beagle dog. Can. J. Physiol. Pharmacol. 72 (1994), Suppl. 1, p. 186.
38. 2 in the conscious beagle dog. Br. J. Pharmacol. 120 (1997), Suppl., 158P.
39. TROVIK T. S., JAEGER R., JORDE R. & SAGER G.: Reduced sensitivity to β-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness. Br. J. Clin. Pharmacol. 38 (1994), 427.
40. VITEK M. & TRAUTWEIN W.: Slow inward current and action potential in cardiac Purkinje fibres. Pflügers Arch. Ges. Physiol. 323 (1971), 204.
41. WANG C., GORDON P. B., HUSTVEDT S. O. et al.: MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 38 (1997), 665.
42. WOLF G. L. & BAUM L.: Cardiovascular toxicity and tissue proton T1 response to manganese injection in dog and rabbit. AJR 141 (1983), 193.
43. WONG S. S., MYERBURG R. J., CAMERON J. S. et al.: Electrophysiological effects of verapamil on cells bordering healed myocardial infarction in the cat. Proc. Soc. Exp. Biol. Med. 171 (1982), 289.